drugset / Trial / NCT05693181
Cord Blood Cells in Patients With Acute SCI
Phase 1/2
Unknown
80 enrolled
Sklifosovsky Institute of Emergency Care
K.L. Hetagurov North-Osetian State University · collabState-Financed Health Facility "Samara Regional Medical Center Dinasty" · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a prospective, single-blinded, single-center, randomized, comparative, interventional clinical study of systemic mononuclear multiple allogenic cord blood cells administration safety and efficiency in patients having acute severe contusion spinal cord injury (ASIA A/B), phase I/II
Timeline
- Start
- 2022-12-05
- Primary completion
- 2024-12-31
- Completion
- 2025-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mononuclear cord blood cells | Cell therapy | 5e+08 cells | Intravenous |